Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
    • GP-001 Documents and records control
    • GP-002 Quality planning
    • GP-003 Audits
    • GP-004 Vigilance system
    • GP-005 HR and training
    • GP-007 Post-market surveillance
    • GP-009 Sales
      • T-009-001
      • R-009-001 Implementation plans
        • R-009-001 Iderma 20230301
        • R-009-001 Sermas 20230301
        • R-009-001 Galderma 20230727
        • R-009-001 Boehringer Ingelheim 20240207
        • R-009-001 Hospital del Mar 20240709
        • R-009-001 ES Boehringer Ingelheim 20241223
        • R-009-001 ES Generalitat Valenciana licitacion contrato menor 20250107
        • R-009-001 ES Licitación SESPA 20250101
        • R-009-001 US Sagimet ICON 20250113
        • R-009-001 ES Sandoz 20250407
        • R-009-001 US Johnson & Johnson 20250505
        • R-009-001 US J&J 20250612
        • R-009-001 BR J&J 20250822
        • R-009-001 ES Aptima 20250911
        • R-009-001 Implementation Plan: Visiba Integration Enhancement
        • R-009-001 US Johnson & Johnson 20251031
        • R-009-001 ES Novartis 20251104
        • R-009-001 UK Pfizer 20260107
        • R-009-001 PL LUX MED Bupa 20260225
    • GP-010 Suppliers
    • GP-012 Design, Redesign and Development
    • GP-018 Infrastructure and facilities
    • GP-019 Non-product software validation
    • GP-023 Change control management
    • GP-050 Data Protection
    • GP-051 Security violations
    • GP-052 Data Privacy Impact Assessment (DPIA)
    • GP-200 Remote Data Acquisition in Clinical Investigations
    • GP-011 Provision of service
    • GP-110 Esquema Nacional de Seguridad
  • Legit.Health Plus Version 1.1.0.0
  • Legit.Health Plus Version 1.1.0.1
  • Legit.Health Utilities
  • Licenses and accreditations
  • Applicable Standards and Regulations
  • Pricing
  • Public tenders
  • Records
  • GP-009 Sales
  • R-009-001 Implementation plans
  • R-009-001 PL LUX MED Bupa 20260225

R-009-001 PL LUX MED Bupa 20260225

  • Deal Id: 16905397789
  • Contract sign date: 2025 12 01 (2025-12-01)
  • Deal name: PL LUX MED Bupa - eDermatology Pilot

Goals​

Goals for 1st year​

GoalMetricTarget
Pave the path for full implementation by building awareness and testing user reaction.User feedback (Doctors & Patients)Positive feedback from F&F group
Assess how the solution works in relation to existing processes at LUX MED.Successful integration into workflowValidated workflow for Release 0.2

Project details summary​

  • Primary Objective: Pave the path for full implementation, build awareness, and test reaction of doctors and patients.

  • Integration Type: Release 0.1 (Manual/No integration via URLs) -> Release 0.2 (Iframe)

  • Features Needed: Severity measurement, malignancy detection, triage support.

  • Conditions of Interest: General Dermatology / Triage

  • Languages Supported: English (Interface & Materials)

  • Integration Needs: Iframe (for Phase 2), JSON/Manual URLs (for Phase 1)

  • Timeline: Start Phase 1 (F&F) Dec 2025, Phase 2 TBD, Full Rollout Sep 2026

  • Users: ~5 doctors (GPs and Nurses)

  • Geographical scope: Poland (Warsaw)

  • Data Volume: ~15-25 patients (Phase 1), ~1500 (Phase 2 TBD)

  • Data Handling: No patient data storage in Phase 1 (Manual URLs)

  • Challenges: Internal IT security/compliance bureaucracy, ensuring usage in manual workflow.

  • Is an ethics committee approval required?: No (Pilot/Service validation)

Customer's Objective Validation​

  • Example Report: N/A
  • Validation: Feedback from "Friends & Family" pilot group.
  • Next Steps: Review F&F results, proceed to Release 0.2 (Iframe), Full Implementation.

Project timeline and milestones​

To achieve the goals, the parties agree on the following timeline.

Project tasks​

🧭 Definition & planning​

TaskDescriptionResponsibleStatus
Project conception and initiationInitial ideation and opportunity scoping with all key stakeholders.Deal Owner, JD-013✅ Done
Definition and planningDefine project details: scope (F&F vs Pilot), key deliverables, timelines.Deal Owner, JD-013✅ Done
Implementation plan definedProject scope, key deliverables, timelines, and required resources are defined.Deal Owner & JD-003 or JD-013 or JD-007✅ Done

📝 Contracting​

TaskDescriptionResponsibleStatus
Offer SentFormal offer/proposal shared with the customer for review.Deal Owner, JD-002✅ Done
Offer ApprovedCustomer reviews and approves the proposed scope, terms, and pricing.✅ Done
Contract ReviewAlign on deliverables, timelines, legal and data terms.✅ Done
Contract SigningFinalize and sign all contractual agreements.✅ Done

🔌 Integration workflow (Phase 1 & 2)​

TaskDescriptionTimelineStatusDependencies
Technical onboardingProvide documentation (PDF with URLs) and guidance for Phase 1.2025-12-03✅ DoneContract signed
Access Delivery (Phase 1)Generate and deliver 10 iframe URLs for manual usage.2025-12-03✅ DoneContract signed
Iframe Integration (Phase 2)Support IT team with Iframe integration for Phase 2 (Release 0.2).TBD⏳ PendingPhase 1 feedback
Preproduction environment TestingValidate integration in pre-prod using sample cases.TBD⏳ PendingIframe setup
Production environment TestingConduct final functional testing with production endpoints.TBD⏳ PendingConcordance validation
Launch Readiness & Go/No-GoFinal checklist review for Phase 2 launch.TBD⏳ Pending

🚀 Project Execution​

TaskDescriptionResponsibleStatus
Phase 1 Execution (F&F)5 doctors/nurses using manual URLs for ~25 patients.Customer, JD-016🔄 Active
Feedback CollectionGather qualitative feedback from doctors and patients via questionnaire.Customer, JD-016🔄 Active
Phase 2 ExecutionExpanded pilot with Iframe integration.Customer, JD-016⏳ Pending
Data AnalysisAnalyze usage metrics and feedback from Phase 1 & 2.JD-021, JD-016, JD-014⏳ Pending

🔁 Follow-up Meetings​

TaskDescriptionResponsibleStatus
Mid-term ReviewReview usage stats (Jan/Feb) and address blockers.JD-016, JD-002✅ Done
Feedback ReviewReview results from F&F pilot questionnaires.JD-016⏳ Pending
Phase 2 KickoffPlan transition to Iframe integration.JD-016, JD-013⏳ Pending

✅ Project Close​

TaskDescriptionResponsibleStatus
Final ReportAnalyze final outcomes, compare against objectives, and document results.JD-021, JD-016⏳ Pending
Define Next StepsRoadmap for full implementation (Sep 2026).JD-021, JD-016⏳ Pending

Project plan​

This project consists of the following phases:

  • Phase 1: Conception and initiation (Completed)
  • Phase 2: Definition and planning (Completed)
  • Phase 3: Phase 1 Execution (Friends & Family - Manual URLs) (Active)
  • Phase 4: Phase 2 Execution (Pilot - Iframe Integration) (Upcoming)
  • Phase 5: Results analysis and report
  • Phase 6: Project close / Conversion to Full Rollout

Phase 1 & 2: Completed​

Phase 3: Phase 1 Execution (Friends & Family)​

Current Status​

  • Access: Provided via 10 static URLs on Dec 3, 2025.
  • Usage: Low initial usage in Jan 2026 (12 uses). Regained activity in Feb 2026.
  • Action Items:
    • Complete feedback collection from initial patient batch.
    • Resolve any access issues with questionnaires.
    • Validate readiness for Phase 2.

Phase 4: Phase 2 Execution (Pilot - Iframe)​

Objectives​

  • Implement "Release 0.2" with proper Iframe integration.
  • Expand user base beyond the initial 5 F&F users.
  • Validate technical integration with LUX MED's IT infrastructure.

Project leads​

TeamCodeLeader of
Legit.HealthJD-002Jorge Juan (Sales/Business Development)
Legit.HealthJD-016Jon Roca (Customer Success Manager)
Legit.HealthJD-013Project Manager
Legit.HealthJD-003Design and Development Manager
Legit.HealthJD-007, JD-010Technology Manager, Software developer
Legit.HealthJD-021Maria Ribagorda (Account Manager)
LUX MEDJakub DąbrowskiProject Coordinator / Product Owner
LUX MEDAndrzej OsuchDirector of Digital Transformation
LUX MEDPiotr PenzaIT Lead
LUX MEDDaria ZurawProject Team

Signature meaning

The signatures for the approval process of this document can be found in the verified commits at the repository for the QMS. As a reference, the team members who are expected to participate in this document and their roles in the approval process, as defined in Annex I Responsibility Matrix of the GP-001, are:

  • Author: Team members involved
  • Reviewer: JD-003 Design & Development Manager, JD-004 Quality Manager & PRRC
  • Approver: JD-001 General Manager

ㅤㅤ ㅤ

Previous
R-009-001 UK Pfizer 20260107
Next
GP-010 Suppliers
  • Goals
    • Goals for 1st year
  • Project details summary
  • Customer's Objective Validation
  • Project timeline and milestones
  • Project tasks
    • 🧭 Definition & planning
    • 📝 Contracting
    • 🔌 Integration workflow (Phase 1 & 2)
    • 🚀 Project Execution
    • 🔁 Follow-up Meetings
    • ✅ Project Close
  • Project plan
  • Phase 1 & 2: Completed
  • Phase 3: Phase 1 Execution (Friends & Family)
    • Current Status
  • Phase 4: Phase 2 Execution (Pilot - Iframe)
    • Objectives
  • Project leads
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI Labs Group S.L.)